Quality of life in fatal disease: The flawed judgement of the social environment

Dorothée Lulé, Benedikt Ehlich, Dirk Lang, Sonja Sorg, Johanna Heimrath, Andrea Kübler, Niels Birbaumer, Albert C. Ludolph

Research output: Contribution to journalArticle

Abstract

Decisions to prolong or shorten life in fatal diseases like amyotrophic lateral sclerosis are strongly influenced by healthy individuals, such as caregivers and physicians. Furthermore, many believe that amyotrophic lateral sclerosis (ALS) patients should decide ahead of time on advanced directives to circumvent confounding effects of subsequent cognitive impairments. The ability of healthy persons (caregivers and age-matched healthy subjects) to anticipate patients' quality of life (QoL), depression and vital decisions was determined in a cross-sectional approach. Eighty-nine ALS patients, 86 caregivers and 102 age-matched healthy subjects were asked to judge ALS patients' QoL and depression and the patients' wish for hastened death. Patients judged their own, the caregivers judged that of the patient under their care, healthy subjects were asked to judge that of a virtual patient. Additionally, healthy persons were asked to judge their own QoL and depression. Patients reported a satisfactory well-being and a low wish for hastened death. Healthy persons rated the patients' QoL significantly lower and the rate of depression significantly higher. The wish for hastened death was significantly lower in the patient group compared to what healthy subjects thought the patient would wish. The assessment by others was closely related to the persons' own well-being. Significant differences were identified between caregiver's perspectives and the patient's own perception of their psychological well-being. Our data suggest that caregivers and the general public significantly underestimate the QoL of ALS patients. A positive affective state can indeed be preserved in a progressive, fatal disease.

Original languageEnglish
Pages (from-to)2836-2843
Number of pages8
JournalJournal of Neurology
Volume260
Issue number11
DOIs
Publication statusPublished - Nov 2013

Fingerprint

Social Environment
Quality of Life
Caregivers
Amyotrophic Lateral Sclerosis
Healthy Volunteers
Depression
Aptitude

Keywords

  • Amyotrophic lateral sclerosis
  • Caregiver
  • Decisions
  • Depression
  • Fatal
  • Quality of life

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Lulé, D., Ehlich, B., Lang, D., Sorg, S., Heimrath, J., Kübler, A., ... Ludolph, A. C. (2013). Quality of life in fatal disease: The flawed judgement of the social environment. Journal of Neurology, 260(11), 2836-2843. https://doi.org/10.1007/s00415-013-7068-y

Quality of life in fatal disease : The flawed judgement of the social environment. / Lulé, Dorothée; Ehlich, Benedikt; Lang, Dirk; Sorg, Sonja; Heimrath, Johanna; Kübler, Andrea; Birbaumer, Niels; Ludolph, Albert C.

In: Journal of Neurology, Vol. 260, No. 11, 11.2013, p. 2836-2843.

Research output: Contribution to journalArticle

Lulé, D, Ehlich, B, Lang, D, Sorg, S, Heimrath, J, Kübler, A, Birbaumer, N & Ludolph, AC 2013, 'Quality of life in fatal disease: The flawed judgement of the social environment', Journal of Neurology, vol. 260, no. 11, pp. 2836-2843. https://doi.org/10.1007/s00415-013-7068-y
Lulé D, Ehlich B, Lang D, Sorg S, Heimrath J, Kübler A et al. Quality of life in fatal disease: The flawed judgement of the social environment. Journal of Neurology. 2013 Nov;260(11):2836-2843. https://doi.org/10.1007/s00415-013-7068-y
Lulé, Dorothée ; Ehlich, Benedikt ; Lang, Dirk ; Sorg, Sonja ; Heimrath, Johanna ; Kübler, Andrea ; Birbaumer, Niels ; Ludolph, Albert C. / Quality of life in fatal disease : The flawed judgement of the social environment. In: Journal of Neurology. 2013 ; Vol. 260, No. 11. pp. 2836-2843.
@article{0340352ff07d4bbebd2061af1fb77fc3,
title = "Quality of life in fatal disease: The flawed judgement of the social environment",
abstract = "Decisions to prolong or shorten life in fatal diseases like amyotrophic lateral sclerosis are strongly influenced by healthy individuals, such as caregivers and physicians. Furthermore, many believe that amyotrophic lateral sclerosis (ALS) patients should decide ahead of time on advanced directives to circumvent confounding effects of subsequent cognitive impairments. The ability of healthy persons (caregivers and age-matched healthy subjects) to anticipate patients' quality of life (QoL), depression and vital decisions was determined in a cross-sectional approach. Eighty-nine ALS patients, 86 caregivers and 102 age-matched healthy subjects were asked to judge ALS patients' QoL and depression and the patients' wish for hastened death. Patients judged their own, the caregivers judged that of the patient under their care, healthy subjects were asked to judge that of a virtual patient. Additionally, healthy persons were asked to judge their own QoL and depression. Patients reported a satisfactory well-being and a low wish for hastened death. Healthy persons rated the patients' QoL significantly lower and the rate of depression significantly higher. The wish for hastened death was significantly lower in the patient group compared to what healthy subjects thought the patient would wish. The assessment by others was closely related to the persons' own well-being. Significant differences were identified between caregiver's perspectives and the patient's own perception of their psychological well-being. Our data suggest that caregivers and the general public significantly underestimate the QoL of ALS patients. A positive affective state can indeed be preserved in a progressive, fatal disease.",
keywords = "Amyotrophic lateral sclerosis, Caregiver, Decisions, Depression, Fatal, Quality of life",
author = "Doroth{\'e}e Lul{\'e} and Benedikt Ehlich and Dirk Lang and Sonja Sorg and Johanna Heimrath and Andrea K{\"u}bler and Niels Birbaumer and Ludolph, {Albert C.}",
year = "2013",
month = "11",
doi = "10.1007/s00415-013-7068-y",
language = "English",
volume = "260",
pages = "2836--2843",
journal = "Journal of Neurology",
issn = "0340-5354",
publisher = "Dr. Dietrich Steinkopff Verlag GmbH and Co. KG",
number = "11",

}

TY - JOUR

T1 - Quality of life in fatal disease

T2 - The flawed judgement of the social environment

AU - Lulé, Dorothée

AU - Ehlich, Benedikt

AU - Lang, Dirk

AU - Sorg, Sonja

AU - Heimrath, Johanna

AU - Kübler, Andrea

AU - Birbaumer, Niels

AU - Ludolph, Albert C.

PY - 2013/11

Y1 - 2013/11

N2 - Decisions to prolong or shorten life in fatal diseases like amyotrophic lateral sclerosis are strongly influenced by healthy individuals, such as caregivers and physicians. Furthermore, many believe that amyotrophic lateral sclerosis (ALS) patients should decide ahead of time on advanced directives to circumvent confounding effects of subsequent cognitive impairments. The ability of healthy persons (caregivers and age-matched healthy subjects) to anticipate patients' quality of life (QoL), depression and vital decisions was determined in a cross-sectional approach. Eighty-nine ALS patients, 86 caregivers and 102 age-matched healthy subjects were asked to judge ALS patients' QoL and depression and the patients' wish for hastened death. Patients judged their own, the caregivers judged that of the patient under their care, healthy subjects were asked to judge that of a virtual patient. Additionally, healthy persons were asked to judge their own QoL and depression. Patients reported a satisfactory well-being and a low wish for hastened death. Healthy persons rated the patients' QoL significantly lower and the rate of depression significantly higher. The wish for hastened death was significantly lower in the patient group compared to what healthy subjects thought the patient would wish. The assessment by others was closely related to the persons' own well-being. Significant differences were identified between caregiver's perspectives and the patient's own perception of their psychological well-being. Our data suggest that caregivers and the general public significantly underestimate the QoL of ALS patients. A positive affective state can indeed be preserved in a progressive, fatal disease.

AB - Decisions to prolong or shorten life in fatal diseases like amyotrophic lateral sclerosis are strongly influenced by healthy individuals, such as caregivers and physicians. Furthermore, many believe that amyotrophic lateral sclerosis (ALS) patients should decide ahead of time on advanced directives to circumvent confounding effects of subsequent cognitive impairments. The ability of healthy persons (caregivers and age-matched healthy subjects) to anticipate patients' quality of life (QoL), depression and vital decisions was determined in a cross-sectional approach. Eighty-nine ALS patients, 86 caregivers and 102 age-matched healthy subjects were asked to judge ALS patients' QoL and depression and the patients' wish for hastened death. Patients judged their own, the caregivers judged that of the patient under their care, healthy subjects were asked to judge that of a virtual patient. Additionally, healthy persons were asked to judge their own QoL and depression. Patients reported a satisfactory well-being and a low wish for hastened death. Healthy persons rated the patients' QoL significantly lower and the rate of depression significantly higher. The wish for hastened death was significantly lower in the patient group compared to what healthy subjects thought the patient would wish. The assessment by others was closely related to the persons' own well-being. Significant differences were identified between caregiver's perspectives and the patient's own perception of their psychological well-being. Our data suggest that caregivers and the general public significantly underestimate the QoL of ALS patients. A positive affective state can indeed be preserved in a progressive, fatal disease.

KW - Amyotrophic lateral sclerosis

KW - Caregiver

KW - Decisions

KW - Depression

KW - Fatal

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=84889591765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889591765&partnerID=8YFLogxK

U2 - 10.1007/s00415-013-7068-y

DO - 10.1007/s00415-013-7068-y

M3 - Article

C2 - 23989341

AN - SCOPUS:84889591765

VL - 260

SP - 2836

EP - 2843

JO - Journal of Neurology

JF - Journal of Neurology

SN - 0340-5354

IS - 11

ER -